Kalino Bio is developing a non‑surgical, hormone‑based fertility control product for dogs and cats that can be administered without anesthesia or operating‑room facilities.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional spay/neuter surgery is invasive, requires anesthesia, and often lacks accessibility for shelters, underserved communities, and pet owners seeking less invasive options, limiting scalable fertility management for dogs and cats.
Solution
Kalino Bio is developing a non‑surgical fertility control product for dogs and cats that leverages an advanced technology platform and veterinary expertise. The solution aims to provide a safe, reversible, and easily administered alternative to surgical sterilization, reducing the need for operating‑room resources and anesthesia. By offering a minimally invasive method, the product seeks to improve animal welfare and expand access to fertility control in resource‑constrained settings. The approach aligns with modern veterinary practice, enabling veterinarians to integrate the treatment into routine care without major workflow changes.
Target Audience
Primary customers are animal shelters, community veterinary clinics, and pet owners who need a less invasive, cost‑effective fertility solution for dogs and cats.
Features
- Non‑surgical, hormone‑based fertility control designed for both dogs and cats
- Administration that does not require anesthesia or operating‑room facilities
- Reversible or long‑acting formulation to allow flexible fertility management
- Developed with veterinary input to ensure safety, efficacy, and compatibility with standard veterinary protocols
- Scalable solution intended for use in shelters, community clinics, and private veterinary practices